Viewing Study NCT02778204


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-02-10 @ 10:02 AM
Study NCT ID: NCT02778204
Status: COMPLETED
Last Update Posted: 2022-01-04
First Post: 2016-05-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vertical HIV exposure View
None Neonates View
None Maraviroc View